9 healthcare orgs stand among Fortune’s ‘most heroic’ places to work

After surveying more than 500,000 workers in organizations that have at least 1,000 employees, Fortune magazine has designated 100 outfits as the best—and “most heroic”—to work for in 2021.

Occupying the overall No. 1 slot is Cisco, the Silicon Valley IT giant, while 29-hospital Texas Health Resources is the highest-placing healthcare concern out of nine to make the list.  

Fortune says it angled its 2021 best-to-work-for criteria to uncover “how trustworthy, caring and fair the company is in times of crises; employees’ physical, emotional and financial health; and the company’s broader community impact” during “this historically challenging year.”

The magazine based scores mostly on the survey responses, weighted 60%, and the other 40% on employers’ reporting of programs created to support people and communities during the COVID crisis.

“Particular attention was paid to how employees’ experiences varied depending on their job role, gender, race/ethnicity, payroll status and other characteristics to ensure that the company is creating a great workplace for all,” Fortune adds.

The full list is posted with sample employee feedback from each of the 100, and the nine healthcare honorees are:

7. Texas Health Resources (Arlington)

19. Northwell Health (New Hyde Park, New York)

28. Southern Ohio Medical Center (Portsmouth)

45. Baptist Health South Florida (Coral Gables)

49. OhioHealth (Columbus)

67. Atlantic Health System (Morristown, New Jersey)

68. BayCare Health System (Clearwater, Florida)

76. Scripps Health (San Diego)

90. Wellstar Health System (Marietta, Georgia)

Dave Pearson

Dave P. has worked in journalism, marketing and public relations for more than 30 years, frequently concentrating on hospitals, healthcare technology and Catholic communications. He has also specialized in fundraising communications, ghostwriting for CEOs of local, national and global charities, nonprofits and foundations.

Around the web

The Outsourcing Facilities Association, a Texas-based trade group, is alleging that supply issues still remain for Ozempic and Wegovy. The group believes the FDA has ignored those issues.

“Now more than ever, we must recognize that our country’s leadership in groundbreaking medical research spurs scientific innovation, improves public health and creates new innovations that save and improve lives nationwide,” Joseph C. Wu, MD, PhD, explained in a statement. 

The technology used to diagnose, treat and manage cardiovascular disease is always evolving, keeping FDA officials quite busy. But have the agency's standards been slipping in recent years? A cardiologist with Cedars-Sinai Medical Center explored that very question.